Related Experiment Video
Updated: Apr 20, 2026

Differentiating Chondrocytes from Peripheral Blood-derived Human Induced Pluripotent Stem Cells
Published on: July 18, 2017
Chondrogenic and Osteogenic Induction from iPS Cells
1Department of Orthopaedics, Dongguk University Ilsan Hospital, 814 Siksa-dong, Goyang, 410-773, Korea.
Abstract:
Articular cartilage (AC) does not heal spontaneously when injured in adults. This incapacity for self-repair after damage ultimately leads to the development of osteoarthritis. In contrast, bone repairs itself without scarring. However, complete bone healing fails to occur in large defects coming from major trauma or malignant tumor resection. Cell therapy has been investigated for these musculoskeletal conditions. Induced pluripotent stem cells (iPSCs) possess the characteristics of embryonic stem cells (ESCs) in potentially unlimited proliferation while avoiding the ethical controversies. However, several issues need to be resolved before iPSCs can be considered as a potential therapeutic measure for cartilage and bone regeneration. The authors developed protocol to examine the in vitro chondrogenesis and osteogenesis from hiPSCs and in vivo cartilage and bone regeneration using animal models.
Related Concept Videos
iPS Cell Differentiation
Induced Pluripotent Stem Cells
Somatic...
Induced Pluripotent Stem Cells
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
EPS and iPS Cells in Disease Research
Somatic to iPS Cell Reprogramming

